<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-24744" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Marfan Syndrome</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Salik</surname>
            <given-names>Irim</given-names>
          </name>
          <aff>Westchester MC/New York Med. College</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Rawla</surname>
            <given-names>Prashanth</given-names>
          </name>
          <aff>Sovah Health, Martinsville, VA</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Irim Salik declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Prashanth Rawla declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>23</day>
          <month>1</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-24744.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>One of the most common inherited disorders affecting connective tissue, Marfan syndrome (MFS), is an autosomal dominant condition with a reported incidence of 1 in 3000 to 5000 individuals. There is a broad range of clinical severity associated with MFS, ranging from isolated features of MFS to neonatal presentation of severe and rapidly progressive disease involving multiple organ systems. The syndrome is associated with classic ocular, cardiovascular, and musculoskeletal abnormalities, although involvement of the lung, skin, and central nervous system may also occur. Decreased life expectancy occurs primarily due to aortic complications. This activity reviews the cause, pathophysiology, and presentation of Marfan syndrome and highlights the role of the interprofessional team in its evaluation and management.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Evaluate&#x000a0;the pathophysiology of Marfan syndrome.</p></list-item><list-item><p>Identify&#x000a0;the cardiovascular alterations in Marfan syndrome.</p></list-item><list-item><p>Assess&#x000a0;the treatment options in patients with Marfan syndrome.</p></list-item><list-item><p>Communicate&#x000a0;the importance of improving care coordination among interprofessional team members to improve outcomes for patients affected by Marfan syndrome.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=24744&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=24744">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-24744.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>One of the most common inherited disorders affecting connective tissue, Marfan syndrome (MFS), is an autosomal dominant condition with a reported incidence of 1 in 3000 to 5000 individuals.<xref ref-type="bibr" rid="article-24744.r1">[1]</xref><xref ref-type="bibr" rid="article-24744.r2">[2]</xref>&#x000a0;The defect is in the&#x000a0;<italic toggle="yes">FBN1</italic>&#x000a0;gene of chromosome 15, which produces fibrillin, a connective tissue protein.<xref ref-type="bibr" rid="article-24744.r3">[3]</xref><xref ref-type="bibr" rid="article-24744.r4">[4]</xref>&#x000a0;There is a broad range of clinical severity associated with MFS, ranging from isolated features of MFS to neonatal presentation of severe and rapidly progressive disease involving multiple organ systems.<xref ref-type="bibr" rid="article-24744.r5">[5]</xref>&#x000a0;The syndrome is associated with classic ocular, cardiovascular, and musculoskeletal abnormalities, although involvement of the lung, skin, and central nervous system may also occur.<xref ref-type="bibr" rid="article-24744.r6">[6]</xref><xref ref-type="bibr" rid="article-24744.r7">[7]</xref> Decreased life expectancy occurs primarily due to aortic complications, including aortic root dilatation and dissection.<xref ref-type="bibr" rid="article-24744.r8">[8]</xref></p>
        <p>The patients with MFS display multiple deformities of the skeleton, including dolichostenomelia (long limbs compared to trunk), arachnodactyly (abnormally long and thin digits), thoracolumbar scoliosis, and&#x000a0;pectus deformities (excavatum and carinatum).<xref ref-type="bibr" rid="article-24744.r9">[9]</xref><xref ref-type="bibr" rid="article-24744.r10">[10]</xref>&#x000a0;Aortic regurgitation, dilatation, and aneurysms&#x000a0;are most common in the cardiovascular system.<xref ref-type="bibr" rid="article-24744.r4">[4]</xref><xref ref-type="bibr" rid="article-24744.r11">[11]</xref>&#x000a0;Mitral valve prolapse can also occur.<xref ref-type="bibr" rid="article-24744.r12">[12]</xref>&#x000a0;Ocular findings include lens dislocation, cataracts, myopia, and retinal detachment.<xref ref-type="bibr" rid="article-24744.r13">[13]</xref>&#x000a0;The diagnosis of MFS is usually made clinically based on typical abnormalities. Craniofacial characteristics, thumb and wrist signs, severe hindfoot valgus, and pectus carinatum are the physical features with the highest diagnostic yield.<xref ref-type="bibr" rid="article-24744.r14">[14]</xref>&#x000a0;There is no specific laboratory test except molecular genetic testing for diagnosing MFS.<xref ref-type="bibr" rid="article-24744.r15">[15]</xref>&#x000a0;No specific treatment cures MFS, but specific interventions may improve certain aspects of the syndrome. Medical therapy with&#x000a0;beta-blockers and other afterload-reducing agents aims to reduce stress on the aortic valve, mitral valve, and aortic root.<xref ref-type="bibr" rid="article-24744.r16">[16]</xref>&#x000a0;Outcome improves with early diagnosis, medical treatment to delay or prevent the progression of aortic dilatation, and timely elective surgery.</p>
      </sec>
      <sec id="article-24744.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Although it has an autosomal dominant inheritance, rare case reports have described recessive fibrillin 1 gene&#x000a0;<italic toggle="yes">(FBN1)</italic>&#x000a0;mutations.<xref ref-type="bibr" rid="article-24744.r17">[17]</xref>&#x000a0;While most individuals with MFS have an affected parent, 25% of patients develop the disease due to a de novo mutation involving the gene <italic toggle="yes">(FBN1)</italic> encoding the connective tissue protein fibrillin-1.<xref ref-type="bibr" rid="article-24744.r18">[18]</xref><xref ref-type="bibr" rid="article-24744.r19">[19]</xref>
<italic toggle="yes">FBN1</italic> is a large gene (65 exons) located&#x000a0;at chromosome 15q-21.1. Fibrillin-1 is a matrix glycoprotein that is the main constituent of elastic fibers.<xref ref-type="bibr" rid="article-24744.r20">[20]</xref><xref ref-type="bibr" rid="article-24744.r21">[21]</xref> In less than 10% of patients with typical Marfan phenotype, no mutation in <italic toggle="yes">FBN1</italic> is identifiable, likely due to complete allele deletion or altered regulation of the <italic toggle="yes">FBN1</italic> gene. In patients with atypical presentations reminiscent of MFS, a mutation in a gene encoding for transforming growth factor-beta receptor <italic toggle="yes">(TGFBR) </italic>may be the cause. Some individuals with <italic toggle="yes">TGFBR1</italic> or <italic toggle="yes">TGFBR2</italic> mutations have clinical features consistent with MFS, while others have features of&#x000a0;1 of&#x000a0;2 other syndromes: Loeys-Dietz syndrome (LDS) or familial thoracic aortic aneurysm (FTAA) syndrome.<xref ref-type="bibr" rid="article-24744.r5">[5]</xref></p>
      </sec>
      <sec id="article-24744.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Approximately&#x000a0;one in every 3,000 to 5,000 individuals is affected.<xref ref-type="bibr" rid="article-24744.r4">[4]</xref>&#x000a0;The disease occurs worldwide, with no preference for race or gender. It exhibits complete penetrance with variable expression.<xref ref-type="bibr" rid="article-24744.r22">[22]</xref>&#x000a0;Twenty-five percent of cases present sporadically due to de novo mutations.<xref ref-type="bibr" rid="article-24744.r2">[2]</xref>&#x000a0;MFS is one&#x000a0;of the most common single-gene malformation syndromes.</p>
      </sec>
      <sec id="article-24744.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The pathophysiology of aortic dilatation in MFS is a complicated process. Fibrillin-1 regulates TGF-beta bioavailability, leading to inflammation, fibrosis, and activation of specific matrix metalloproteinases (MMPs), particularly MMP-2 and MMP-9.<xref ref-type="bibr" rid="article-24744.r23">[23]</xref>&#x000a0;Cystic medial degeneration of the aorta occurs when an accumulation of mucopolysaccharide cysts leads to the loss of vascular smooth muscle cells. Aortic wall weakening is due to increased release of MMP, cytokines, chemokines, prostaglandin derivatives, and elastic degradation fragments. In conjunction with decreased collagen, these factors reduce aortic structural integrity and lead to aneurysmal dilatation.<xref ref-type="bibr" rid="article-24744.r24">[24]</xref> Reduced or altered forms of fibrillin-1 can stimulate the release of sequestered TGF-beta and increase its activity.<xref ref-type="bibr" rid="article-24744.r25">[25]</xref>&#x000a0;MFS is, therefore, caused by vascular remodeling due to a combination of structural microfibril changes, excess TGF-beta, and overexpression of MMP-2 and MMP-9.<xref ref-type="bibr" rid="article-24744.r24">[24]</xref> The role of TGF-beta in the pathophysiology of MFS has&#x000a0;been solidified by the use of the therapeutic angiotensin-converting enzyme inhibitors and angiotensin 2 receptor blockers (ARBs), both proven to decrease TGF-beta activity. Early studies in a mouse model of MFS have shown the utility of a TGF-beta-neutralizing antibody or ARB losartan in treating the disease.<xref ref-type="bibr" rid="article-24744.r26">[26]</xref> Comparatively, mutant mice treated with propranolol only exhibited a moderate reduction in the rate of aortic root dilation. Human studies substantiated that ARB therapy significantly reduced the rate of change in the aortic root diameter compared to beta-blocker therapy alone.<xref ref-type="bibr" rid="article-24744.r27">[27]</xref>&#x000a0;Various conditions with pronounced clinical overlap with MFS are caused by primary mutations in genes encoding direct effectors&#x000a0;or&#x000a0;regulators of TGF-beta signaling, including Loeys-Dietz syndrome (LDS) and Shprintzen-Goldberg syndrome (SGS).</p>
      </sec>
      <sec id="article-24744.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Histologic features of the medial layer of the aortic root in patients with MFS&#x000a0;include cystic medial necrosis, fibrosis, and loss of smooth muscle cells.<xref ref-type="bibr" rid="article-24744.r28">[28]</xref><xref ref-type="bibr" rid="article-24744.r29">[29]</xref>&#x000a0;Although cystic medial necrosis and the other histologic findings are not specific to MFS, greater elastin fragmentation has been shown in patients with aortic root aneurysms with MFS compared to those without a connective tissue diagnosis.<xref ref-type="bibr" rid="article-24744.r30">[30]</xref></p>
      </sec>
      <sec id="article-24744.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>History and physical for patients with MFS encompass various organ systems. Of primary concern is cardiac pathology. Aortic root disease, leading to aortic regurgitation, aneurysmal dilatation, and dissection, is the primary cause of morbidity and mortality in MFS in up to 60% to 80% of patients.</p>
        <p>
<bold>Revised Criteria for Patients with MFS</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Aortic root dilatation</p>
          </list-item>
          <list-item>
            <p>Family history of aortic root dilatation</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">FBN1</italic> mutation previously associated with aortic root dilatation</p>
          </list-item>
        </list>
        <p>Dilatation may also involve other segments of the thoracic aorta, the abdominal aorta, the root of the pulmonary artery, or even the carotid and intracranial arteries. However, this is much less frequent than observed in LDS.</p>
        <p>As recommended in the 2010 American College of&#x000a0;Cardiology/American&#x000a0;Heart&#x000a0;Association/American&#x000a0;Association for Thoracic Surgery (ACC/AHA/AATS) thoracic aorta guidelines, echocardiography is recommended at initial diagnosis and&#x000a0;6 months to assess the aortic root and ascending aorta in patients with MFS.<xref ref-type="bibr" rid="article-24744.r31">[31]</xref>&#x000a0;A 6-month echocardiogram is performed to confirm the stability of the aortic dimension. Nomograms and Z-scores are used to identify aortic dilatation because the normal range for aortic diameter varies with body size and age. Undiagnosed and untreated MFS is often associated with aortic dissection that begins above the coronary ostia and can extend the entire length of the aorta, known as a type 1 dissection in the DeBakey classification.&#x000a0;Based on a review from the International Registry of Aortic Dissection (IRAD),<xref ref-type="bibr" rid="article-24744.r32">[32]</xref>&#x000a0;MFS causes an aortic dissection in 50% of those under age 40, compared to only 2% of older patients with aortic dissection and no patients over age 70.<xref ref-type="bibr" rid="article-24744.r33">[33]</xref></p>
        <p>Aortic dissection and rupture are preventable in patients with MFS by replacement of the ascending aorta.&#x000a0;Prophylactic surgery&#x000a0;is recommended when the ascending aorta's diameter at the aortic sinuses' level reaches 5.0 cm. Patients with an aortic diameter of less than 2.75 cm/m2 are considered to be at low risk of dissection, those with 2.75 to 4.24 cm/m2&#x000a0; are at moderate risk, and those with greater than 4.25 cm/m2 are at high risk. A family history of dissection, increased rate of aortic dilation (greater than 2 mm per year), severe aortic valve regurgitation with left ventricular dilation, and relative feasibility of aortic valve-sparing surgery are also indicators for early surgical intervention.<xref ref-type="bibr" rid="article-24744.r34">[34]</xref></p>
        <p>Mitral valve prolapse (MVP) is identified in 40% to 54% of patients with MFS.<xref ref-type="bibr" rid="article-24744.r35">[35]</xref><xref ref-type="bibr" rid="article-24744.r36">[36]</xref>&#x000a0;Since it is nonspecific, only 1 point in the systemic score is assigned for MVP.<xref ref-type="bibr" rid="article-24744.r37">[37]</xref>&#x000a0;The frequency of MVP in MFS increases with age and is more prevalent in women. Tricuspid valve prolapse may also occur. Patients with MFS and MVP have mild regurgitation (MR).<xref ref-type="bibr" rid="article-24744.r35">[35]</xref>&#x000a0;In these patients, the worsening of MR is due to spontaneous rupture of the chordae tendineae or infective endocarditis. Heart failure caused by MVP and MR represents a major source of morbidity and mortality in young children with rapidly progressive MFS. Due to disrupted granular fibers from the proximal aorta to the base of the innominate artery, care should be taken without cross-clamp placement for patients with MFS with MVP.<xref ref-type="bibr" rid="article-24744.r38">[38]</xref>&#x000a0;The presence of aortic regurgitation should be taken into account when performing cardioplegia to ensure adequate myocardial protection. Freedom from moderate or greater mitral regurgitation at 5, 10, and 20 years is about 95%, 89%, and 69%, respectively.<xref ref-type="bibr" rid="article-24744.r39">[39]</xref> Patients with MFS may have cardiomyopathy with biventricular enlargement and mild systolic dysfunction.<xref ref-type="bibr" rid="article-24744.r40">[40]</xref>&#x000a0;Patients may exhibit proximal ascending aortic dilation, proximal main pulmonary artery dilation, thickening and prolapse of the atrioventricular valves, and mitral annular calcification.</p>
        <p>Patients with&#x000a0;MFS have excess linear growth of the long bones and joint laxity. Some have reduced joint mobility, particularly of the elbow and digits. Individuals with MFS are taller than the general population.<xref ref-type="bibr" rid="article-24744.r41">[41]</xref>&#x000a0;They have disproportionately long extremities compared to the length of the trunk or dolichostenomelia. Patients typically have arachnodactyly with a positive thumb sign where the entire distal phalanx protrudes beyond the ulnar border of a closed&#x000a0;fist. Patients also exhibit a positive wrist sign where the top of the thumb covers the whole fingernail of the fifth finger when wrapped around the contralateral wrist. MFS commonly exhibit either pectus carinatum or pectus excavatum. Pes planus, or flatfoot deformity, caused by ligamentous laxity, leads to longer and narrower feet than the average person.<xref ref-type="bibr" rid="article-24744.r42">[42]</xref></p>
        <p>Patients present with diagnostic findings for scoliosis, including a vertical difference of equal to 1.5 cm between the left and right hemithorax ribs and a Cobb angle of at least 20 degrees. If scoliosis is absent, exaggerated kyphotic thoracolumbar spinal curvature can be considered to aid in diagnosing MFS. Radiographic findings of MFS scoliosis are indistinguishable from adolescent idiopathic scoliosis (AIS). Scoliosis associated with MFS is less responsive to a brace; therefore, a brace is only utilized in skeletally immature patients with scoliotic curves less than 25 degrees.<xref ref-type="bibr" rid="article-24744.r43">[43]</xref>&#x000a0;Surgery should be&#x000a0;considered&#x000a0;in patients with curves greater than 45 degrees, although it is associated with higher revision and complication rates than AIS.<xref ref-type="bibr" rid="article-24744.r7">[7]</xref>&#x000a0;In a retrospective, case-controlled study by Gjolaj et al.,<xref ref-type="bibr" rid="article-24744.r44">[44]</xref>&#x000a0;patients with MFS scoliosis had higher rates of cerebrospinal fluid leaks, an increased likelihood of complications related to implant placement, and more surgical revisions secondary to fixation failure and a spinal fracture. Studies have also reported higher blood loss and longer operative times than in patients with AIS.<xref ref-type="bibr" rid="article-24744.r45">[45]</xref><xref ref-type="bibr" rid="article-24744.r46">[46]</xref> Surgeons must also consider the unique anatomic features of patients with MFS, including narrow pedicles, wide transverse processes, and vertebral scalloping.<xref ref-type="bibr" rid="article-24744.r9">[9]</xref></p>
        <p>An acetabular protrusion, or protrusio acetabuli, can be diagnosed by the medial protrusion of the acetabulum equal to 3 mm beyond the ilio-ischial (Kohler) line. This reflects&#x000a0;1 of the main causes of osteoarthritis in patients with MFS. Degeneration of the hip joint is secondary to ligamentous laxity combined with this bony abnormality. Thakkar et al.<xref ref-type="bibr" rid="article-24744.r47">[47]</xref>&#x000a0;noted that hip dislocations are caused by impingement on the deeper acetabulum or ligamentous laxity, and implant failure may be secondary to osteoporosis or osteopenia. Annual ophthalmologic evaluation is recommended for all patients with MFS secondary to ectopia lentis, which occurs in 50% to 80% of patients.<xref ref-type="bibr" rid="article-24744.r48">[48]</xref>&#x000a0;It is diagnosed by slit-lamp examination after maximal dilatation of the pupil; the lens is usually displaced upward and temporally. Other ocular findings in MFS include a flat cornea, retinal detachment, glaucoma, and early cataract formation.<xref ref-type="bibr" rid="article-24744.r49">[49]</xref></p>
        <p>Dural ectasia results from enlargement of the spinal canal secondary to vertebral bone enlargement, most commonly in the lumbosacral region.<xref ref-type="bibr" rid="article-24744.r50">[50]</xref>&#x000a0;Dural ectasia is also seen in LDS and SGS and the vascular form of Ehlers-Danlos syndrome. It is present in more than two-thirds of patients with MFS and commonly presents with pain.<xref ref-type="bibr" rid="article-24744.r51">[51]</xref>&#x000a0;Pain may be associated with periosteal pressure, erosion of lumbosacral elements, traction of the nerve roots, or sacral microfractures secondary to osteopenia. A mouse model of MFS revealed higher dural levels of TGF-&#x000df; caused by fibrillin-1 deficiency.<xref ref-type="bibr" rid="article-24744.r52">[52]</xref>&#x000a0;These changes increase the risk of surgical complications, including spinal fracture and dural injury.</p>
        <p>Patients with MFS develop lung bullae secondary to emphysematous pulmonary changes predominantly in the upper lobes, predisposing them to spontaneous pneumothorax. Patients may exhibit skin striae or striae atrophicae in MFS, owing to the disease as long as they are not associated with pronounced weight loss or pregnancy. Recurrent or incisional hernia and a high-arched palate may occur but are not included in the systemic score since these features are clinically nonspecific.<xref ref-type="bibr" rid="article-24744.r53">[53]</xref></p>
      </sec>
      <sec id="article-24744.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>In 1996, criteria for diagnosing&#x000a0;MFS, known as Ghent nosology, were originally proposed. These criteria relied on major and minor clinical manifestations of the syndrome. Aortic root dilatation and ectopia lentis are cardinal features of the disease, and other systemic features involving the skeletal and cardiovascular organ systems and ocular and vertebral anomalies support the diagnosis. Major criteria included ectopia lentis, aortic root dilatation involving the sinuses of Valsalva or aortic dissection, and lumbosacral dural ectasia by computed tomography or magnetic resonance imaging, family or genetic history, and&#x000a0;4 of&#x000a0;8 typical skeletal manifestations. These criteria underwent revision in 2010 due to various limitations, including insufficient validation, limited applicability to children, and an inability to exclude syndromes such as LDS and SGS. The 2010 revised Ghent nosology puts greater weight on aortic root&#x000a0;dilatation/dissection&#x000a0;and ectopia lentis as the cardinal clinical features of MFS and testing for mutations in FBN1.<xref ref-type="bibr" rid="article-24744.r53">[53]</xref></p>
        <p>
<bold>Systemic Score</bold>
</p>
        <p>The revised Ghent nosology includes the following scoring system for systemic features:</p>
        <list list-type="bullet">
          <list-item>
            <p>Wrist and thumb sign: 3 points</p>
          </list-item>
          <list-item>
            <p>Wrist&#x000a0;or&#x000a0;thumb sign: 1 point</p>
          </list-item>
          <list-item>
            <p>Pectus carinatum deformity: 2 points</p>
          </list-item>
          <list-item>
            <p>Pectus excavatum or chest asymmetry: 1 point</p>
          </list-item>
          <list-item>
            <p>Hindfoot deformity: 2 points</p>
          </list-item>
          <list-item>
            <p>Plain pes planus: 1 point</p>
          </list-item>
          <list-item>
            <p>Pneumothorax: 2 points</p>
          </list-item>
          <list-item>
            <p>Dural ectasia: 2 points</p>
          </list-item>
          <list-item>
            <p>Protrusio acetabuli: 2 points</p>
          </list-item>
          <list-item>
            <p>Reduced upper&#x000a0;segment/lower&#x000a0;segment ratio and increased arm&#x000a0;span/height and no severe scoliosis: 1 point</p>
          </list-item>
          <list-item>
            <p>Scoliosis or thoracolumbar kyphosis: 1 point</p>
          </list-item>
          <list-item>
            <p>Reduced elbow extension (equal to 170 degrees with full extension): 1 point</p>
          </list-item>
          <list-item>
            <p>At a minimum, 3 of the following&#x000a0;5 features: Dolichocephaly (reduced cephalic index or head&#x000a0;width/length&#x000a0;ratio), enophthalmos, down-slanting palpebral fissures, malar hypoplasia, retrognathia): 1 point</p>
          </list-item>
          <list-item>
            <p>Skin striae: 1 point</p>
          </list-item>
          <list-item>
            <p>Myopia greater than 3 diopters: 1 point</p>
          </list-item>
          <list-item>
            <p>Mitral valve prolapse: 1 point</p>
          </list-item>
          <list-item>
            <p>A systemic score equal to 7 indicates significant systemic involvement.<xref ref-type="bibr" rid="article-24744.r53">[53]</xref>&#x000a0;</p>
          </list-item>
        </list>
        <p>In patients with no family history of MFS, the presence of&#x000a0;1 of any of the following criteria is diagnostic for MFS:</p>
        <list list-type="bullet">
          <list-item>
            <p>Aortic criterion (aortic root dissection or diameter Z equal to 2) and&#x000a0;ectopia lentis*</p>
          </list-item>
          <list-item>
            <p>Aortic criterion (aortic root dissection or diameter Z equal to 2)&#x000a0;and&#x000a0;a causal FBN1 mutation</p>
          </list-item>
          <list-item>
            <p>Aortic criterion (aortic diameter Z equal to 2 or aortic root dissection)&#x000a0;and&#x000a0;a systemic score equal to 7*</p>
          </list-item>
          <list-item>
            <p>Ectopia lentis&#x000a0;and&#x000a0;an identified causal FBN1 mutation in an individual with an aortic aneurysm</p>
          </list-item>
        </list>
        <p>In patients with a&#x000a0;family history of MFS, the presence of&#x000a0;1 of any of the following criteria is diagnostic for MFS:</p>
        <list list-type="bullet">
          <list-item>
            <p>Ectopia lentis</p>
          </list-item>
          <list-item>
            <p>A systemic score equal to&#x000a0; 7 points*</p>
          </list-item>
          <list-item>
            <p>Aortic criterion (aortic diameter Z equal to 3 below 20 years old, Z equal to 2 above 20 years, or aortic root dissection)*</p>
          </list-item>
        </list>
        <p>For criteria with an asterisk (*), the diagnosis of MFS can be made only in the absence of discriminating features of Shprintzen-Goldberg syndrome, Loeys-Dietz syndrome, or vascular Ehlers-Danlos syndrome and&#x000a0;after&#x000a0;<italic toggle="yes">TGFBR1/2</italic>,&#x000a0;collagen biochemistry, or <italic toggle="yes">COL3A1</italic> testing if indicated. Later data suggest that additional gene mutations, including those in&#x000a0;<italic toggle="yes">SMAD3</italic>,&#x000a0;<italic toggle="yes">TGFB2</italic>, and&#x000a0;<italic toggle="yes">SKI, should also be excluded</italic>.</p>
        <p>The revised Ghent nosology recommends the following categories for individuals younger than 20 years old with features of MFS who do not meet diagnostic criteria for MFS:</p>
        <list list-type="bullet">
          <list-item>
            <p><italic toggle="yes">Nonspecific connective tissue disorder</italic> applies if the systemic score is less than 7 or&#x000a0;aortic root measurements are borderline (Z less than 3) without an FBN1 mutation.</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Potential MFS</italic> applies if an <italic toggle="yes">FBN1</italic> mutation is identified in a sporadic or familial case but the aortic root Z-score is less than 3.<xref ref-type="bibr" rid="article-24744.r53">[53]</xref>&#x000a0;</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-24744.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Beta-blockers, noninvasive monitoring, restriction of vigorous physical exercise, and elective repair of the aorta have a greatly&#x000a0;improved prognosis. In 1968, Bentall and De Bono introduced the Bentall procedure as the standard surgical approach for patients with MFS. A polyethylene conduit is attached to a mechanical aortic valve, replacing the dilated ascending aorta and aortic root.<xref ref-type="bibr" rid="article-24744.r54">[54]</xref>&#x000a0;Both coronary arteries are then reimplanted. Multicenter studies documented an early mortality rate of 1.5% and a survival rate of 84% at&#x000a0;5 years, 75% at&#x000a0;10 years, and 59% at 20 years. Rates of thromboembolism and endocarditis at 20 years have been 7% and 10%, respectively.<xref ref-type="bibr" rid="article-24744.r55">[55]</xref>&#x000a0;The mean age of surgery is 32; mechanical aortic valves are the preferred device due to their longevity.</p>
        <p>Patients require lifelong anticoagulation secondary to mechanical valve replacement. For patients in whom anticoagulation is not recommended, valve-sparing techniques have been adopted, including the Yacoub technique and the valve reimplantation or David technique. With the Yacoub technique, the sinuses of Valsalva undergo resection and replacement with a vascular graft and coronary artery reimplantation; optimal patients have sinus or aortic dilation without annular dilation. The David technique involves reimplanting the native aortic valve into the graft for patients with annular involvement.<xref ref-type="bibr" rid="article-24744.r56">[56]</xref> Twenty-five percent of patients with MFS undergoing valve-sparing procedures have aortic regurgitation at 10 years, secondary to disease progression. Valve-sparing procedures have lower operative mortality than the Bentall procedure at 5 years, 89% vs. 96%, and reduced incidence of reoperation at&#x000a0;5 years, 92% vs. 84%.<xref ref-type="bibr" rid="article-24744.r57">[57]</xref></p>
        <p>The 2010 ACC/AHA/AATS guidelines for thoracic aortic disease include recommendations for MFS. Patients should have echocardiography performed at the time of diagnosis and&#x000a0;6 months later to determine aortic root and ascending aortic diameters and their growth rate.<xref ref-type="bibr" rid="article-24744.r31">[31]</xref>&#x000a0;Regular aortic diameter monitoring is recommended for patients at risk for aortic dissection using computed tomography (CT), transthoracic echocardiography, and magnetic resonance imaging (MRI) to identify patients at risk for aortic dissection.<xref ref-type="bibr" rid="article-24744.r58">[58]</xref>&#x000a0;These imaging modalities provide information on the classification, origin, and extent of dissection, potential areas of hemorrhage, and other sequelae. Spiral CT angiography is the most frequently used modality worldwide for diagnosing TAAs and the degree of aneurysmal dilatation. CT limitations include aortic artifacts secondary to cardiac motion and implanted devices. Iodinated contrast-induced nephropathy can also occur in selected patients, and the use of repeated episodes of ionizing radiation exposure should be weighed in pediatric patients who require multiple scans in their lifetime. A Z-score, which designates a number of standard deviations from the mean for appropriate&#x000a0;age and size matched with the normal population, should be used to&#x000a0;monitor aortic diameter via CT scan serially. MRI is an alternative to CT in stable patients with suspected thoracic aortic disease, providing information on aortic morphology, ventricular dimension and function, and valvular regurgitation. MRI also allows monitoring of systemic manifestations of MFS, including dural ectasia, scoliosis, chest deformities, and protrusio acetabuli.</p>
        <p>Transthoracic echocardiography is the primary modality in diagnosing MFS. However, transesophageal echocardiography is utilized in suspected dissection situations to measure the aortic root's maximal dimension with the parasternal long-axis view. The leading-edge-to-leading-edge technique in diastole is implemented in adults, while the inner-edge-to-inner-edge technique in systole is utilized among pediatric cardiologists. For MFS, aortic diameter at the sinuses of Valsalva is the key measurement since this is at greatest risk for aortic dissection, and monitoring is via echocardiography. A greater length of aortic dilation is associated with a worse prognosis.<xref ref-type="bibr" rid="article-24744.r59">[59]</xref>&#x000a0;Aortic root measurements should&#x000a0;be parallel to the plane of the aortic valve and perpendicular to the axis of blood flow in the end-diastole.</p>
        <p>In a retrospective analysis of 140 patients with MFS with FBN1 mutations who had undergone routine thoracoabdominal CT or MRI as part of their follow-up, about one-third had incidental findings of peripheral vascular aneurysms, with 55% of these patients requiring intervention.<xref ref-type="bibr" rid="article-24744.r60">[60]</xref> Another prospective series systematically examined the supra-aortic trunks, the arteries of the upper and lower extremities, the aortoiliac arteries, and the visceral branches of the abdominal aorta in 21 patients with MFS. Ten (67%) had peripheral vascular arterial aneurysms, and 2 patients underwent semi-urgent repair.<xref ref-type="bibr" rid="article-24744.r61">[61]</xref></p>
        <p>When ascending aortic dimensions are stable, and there is no identified aortic disease, cross-sectional imaging is repeated every 3 to 5 years before elective operation and annually if the aortic diameter is less than 45 mm. However, if the aortic diameter is 45 mm or enlarges, more frequent imaging is suggested, up to twice annually, and may indicate the need for surgery. More frequent imaging is also prudent if the aortic diameter shows a rapid change (equal to 0.5&#x000a0;cm per year)&#x000a0;or if the heart or valve function is circumspect.<xref ref-type="bibr" rid="article-24744.r53">[53]</xref>&#x000a0;In the pediatric population with MFS,&#x000a0;annual imaging is recommended if the aortic size is stable and not markedly enlarged. Since no validated age-specific aortic diameters can be used to&#x000a0;determine imaging intervals, aortic measurement comparisons should use body surface area. Individuals under 20 years of age with systemic findings suggestive of MFS should have annual echocardiograms due to the potential risk of aortic disease.<xref ref-type="bibr" rid="article-24744.r53">[53]</xref></p>
        <p>As noted in the 2010 American College of&#x000a0;Cardiology/American&#x000a0;Heart&#x000a0;Association/American Association for Thoracic Surgery&#x000a0;(ACC/AHA/AATS)&#x000a0;thoracic aorta guidelines, beta-blockers are recommended in adults with MFS and aortic aneurysm to lower the rate of aortic dilatation.<xref ref-type="bibr" rid="article-24744.r31">[31]</xref> Beta-blockers decrease myocardial contractility and pulse pressure and may improve the elastic properties of the aorta in patients with an aortic root diameter of less than 40 mm.<xref ref-type="bibr" rid="article-24744.r62">[62]</xref>&#x000a0;Medication&#x000a0;is recommended in patients with aortic root enlargement, a family history of aortic root enlargement, or a mutation previously associated with aortic disease. Dosing adjustments should be made to maintain the heart rate after submaximal exercise to less than 100&#x000a0;beats/minute&#x000a0;in adults and less than 110&#x000a0;beats/minute&#x000a0;in children.<xref ref-type="bibr" rid="article-24744.r53">[53]</xref>&#x000a0;Although propranolol&#x000a0;was the first beta-blocker demonstrated to slow aortic dilation, longer-acting agents such as atenolol and metoprolol are also options. Labetalol is used among pregnant women because atenolol may impair fetal growth.</p>
        <p>Beta-blocker therapy is also recommended for children with MFS and aortic aneurysm, though data in children is inconclusive. In an observational study, 44 children and adolescents with MFS were followed for almost&#x000a0;4 years.<xref ref-type="bibr" rid="article-24744.r63">[63]</xref>&#x000a0;The 20 patients on beta-blocker therapy and the&#x000a0;6 patients taking a calcium channel blocker had a slower absolute aortic growth rate. In a retrospective study of 63 children that compared beta-blocker therapy to no therapy,<xref ref-type="bibr" rid="article-24744.r64">[64]</xref>&#x000a0;there was no significant variation in the rate of change in aortic root measurements between the 2 groups at the study's end, and there were more side effects in treated patients.</p>
        <p>While data are limited, adding an angiotensin 2 receptor blocker as tolerated to beta-blocker therapy may slow the rate of aortic root dilation in patients with MFS, as evidenced in the 2010&#x000a0;ACC/AHA/AATS guidelines. Renin-angiotensin system blockers may alleviate the clinical manifestations of MFS by blocking TGF-beta signaling.<xref ref-type="bibr" rid="article-24744.r26">[26]</xref>&#x000a0;The beneficial effects of&#x000a0;angiotensin-converting&#x000a0;enzyme (ACE) inhibitors in MFS are attributed to central blood pressure control and the reduction of aortic wall stiffness.<xref ref-type="bibr" rid="article-24744.r65">[65]</xref>&#x000a0;In a 2005 nonrandomized study, patients with MFS treated with ACE inhibition showed improved outcomes regarding aortic growth rate compared to those treated with beta-adrenergic blocker therapy over&#x000a0;3 years.<xref ref-type="bibr" rid="article-24744.r27">[27]</xref>&#x000a0;Angiotensin 2 stimulates the proliferation of smooth muscle cells, increases fibrosis, attenuates the expression of MMP-2 and MMP-9, and reduces apoptosis through binding to the angiotensin type 1 (AT1) receptors in the aortic wall. Data from animal models suggest that AT1 receptor antagonists reduce TGF-beta levels and can prevent the pathogenesis of MFS. Chiu et al.<xref ref-type="bibr" rid="article-24744.r66">[66]</xref>&#x000a0;have shown that losartan, in combination with beta-blockade, slows the progression of aortic root dilation more than beta-blockade alone in patients with MFS. Groenink et al.<xref ref-type="bibr" rid="article-24744.r67">[67]</xref>&#x000a0;provided additional evidence in the adult MFS population that losartan delays aortic root dilation of a native aortic root and decreases aortic arch dilation in a patient with prior aortic root replacement.</p>
        <p>A randomized trial comparing losartan with atenolol in 608 children and adults with MFS and aortic Z-scores greater than 3.0 found no significant difference in the rate of aortic root dilation between the&#x000a0;2 treatment groups over&#x000a0;3 years.<xref ref-type="bibr" rid="article-24744.r68">[68]</xref>&#x000a0;Both treatments showed a comparable and significant decline in aortic root dilation relative to body surface area. The 3-year rates of aortic root surgery, aortic dissection, and death were similar in the losartan and atenolol treatment groups. There is scant evidence regarding the efficacy of ACE inhibitor therapy in patients with MFS.<xref ref-type="bibr" rid="article-24744.r69">[69]</xref>&#x000a0;A small randomized trial comparing perindopril with placebo (in addition to&#x000a0;standard&#x000a0;beta-blocker&#x000a0;therapy) was retracted.<xref ref-type="bibr" rid="article-24744.r70">[70]</xref> Although no other drug therapy has been officially established, statins may attenuate aortic root dilation in a mouse model of&#x000a0;MFS by reducing the activity of vascular smooth muscle cells in the Marfan aorta.<xref ref-type="bibr" rid="article-24744.r71">[71]</xref></p>
        <p>Both animal and human data suggest that calcium channel blocker therapy may increase the risk of aortic complications.<bold>&#x000a0;</bold>Marfan mice treated with calcium channel blockers demonstrated aneurysm expansion, rupture, and premature death. Patients with&#x000a0;MFS and other forms of thoracic aortic aneurysm taking calcium channel blockers have an increased risk of aortic dissection and the need for aortic surgery.<xref ref-type="bibr" rid="article-24744.r72">[72]</xref>&#x000a0;An American Heart Association expert panel recommends low to moderate-intensity exercise (approximately&#x000a0;4 to&#x000a0;6 metabolic equivalents) for most patients with MFS. However, those with aortic root or&#x000a0;valve replacement may tolerate less.<xref ref-type="bibr" rid="article-24744.r73">[73]</xref>&#x000a0;Patients with MFS should avoid contact sports, exercise to exhaustion, and isometric activities, including the Valsalva maneuver.<xref ref-type="bibr" rid="article-24744.r53">[53]</xref></p>
        <p>Elective replacement of aortic root disease in advance of critical enlargement is integral, as illustrated in a series of 675 patients with MFS from Johns Hopkins in which the 30-day mortality for elective, urgent (within 7 days of surgical consultation), or emergency repair (within 24 hours of consultation) was 1.5%, 2.6%, and 11.7%, respectively.<xref ref-type="bibr" rid="article-24744.r74">[74]</xref>&#x000a0;In another review, the&#x000a0;actuarial survival&#x000a0;at 5, 10, and 20 years&#x000a0;of 231 patients who underwent elective aortic root replacement at Johns Hopkins was 88%, 81%, and 75%, respectively.<xref ref-type="bibr" rid="article-24744.r75">[75]</xref>&#x000a0;The 2010&#x000a0;ACC/AHA/AATS guidelines recommend an elective operation for patients with MFS at an external diameter of equal to 50 mm to avoid acute dissection or rupture.<xref ref-type="bibr" rid="article-24744.r31">[31]</xref>&#x000a0;Indications for surgical repair at an external diameter less than 50 mm include rapid growth (greater than 5&#x000a0;mm per year),&#x000a0;family history of an aortic dissection at a diameter less than 50 mm, or progressive aortic valve regurgitation. The guidelines indicate that surgical repair is appropriate if the maximal cross-sectional area (square centimeters) of the ascending aorta or root divided by the patient's height in meters is greater than 10.<xref ref-type="bibr" rid="article-24744.r76">[76]</xref>&#x000a0;In the pediatric population, dissection is rare; therefore, surgical indications include aneurysms that show rapid enlargement (greater than 10&#x000a0;mm per year)&#x000a0;and progressive aortic insufficiency.<xref ref-type="bibr" rid="article-24744.r77">[77]</xref></p>
        <p>There is conflicting data on the safety profile of pregnant women with MFS. The 2010 thoracic aortic disease guidelines urge pregnancy avoidance if the aortic root diameter exceeds 40 mm and further recommend prophylactic aortic root replacement in women who attempt pregnancy. The European and Canadian guidelines report an aortic root diameter of 45 mm to be considered safe.&#x000a0;In a 2012 study, there was a significantly higher rate of aortic growth documented during pregnancy than at baseline.<xref ref-type="bibr" rid="article-24744.r78">[78]</xref> In previously pregnant women, adverse outcomes and elective aortic surgery during long-term follow-up were more common than in women who remained childless. In women devoid of cardiac complications with MFS, pregnancy is well tolerated up to an aortic root diameter of 45 mm with proper clinical care. In the same vein, pregnancy should be strongly discouraged in women with a history of aortic dissection secondary to the high risk of aortic complications.<xref ref-type="bibr" rid="article-24744.r79">[79]</xref></p>
      </sec>
      <sec id="article-24744.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>While assessing a patient with&#x000a0;MFS, the following differential diagnoses should be considered:</p>
        <list list-type="bullet">
          <list-item>
            <p>LDS</p>
          </list-item>
          <list-item>
            <p>SGS</p>
          </list-item>
          <list-item>
            <p>Mitral valve prolapse syndrome</p>
          </list-item>
          <list-item>
            <p>Congenital contractural arachnodactyly</p>
          </list-item>
          <list-item>
            <p>Weill-Marchesani syndrome&#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Ectopia lentis syndrome</p>
          </list-item>
          <list-item>
            <p>Familial thoracic aortic aneurysm and dissection syndrome</p>
          </list-item>
          <list-item>
            <p>Familial thoracic aortic aneurysm and dissection syndrome&#x000a0;with bicuspid aortic valve</p>
          </list-item>
          <list-item>
            <p>Familial thoracic aortic aneurysm and dissection syndrome with patent ductus arteriosus</p>
          </list-item>
          <list-item>
            <p>Homocystinuria</p>
          </list-item>
          <list-item>
            <p>Arterial tortuosity syndrome</p>
          </list-item>
          <list-item>
            <p>Ehlers-Danlos syndrome (vascular type)</p>
          </list-item>
          <list-item>
            <p>Ehlers-Danlos syndrome (cardiac valvular subtype)</p>
          </list-item>
          <list-item>
            <p>Stickler syndrome (hereditary arthro-ophthalmopathy)</p>
          </list-item>
          <list-item>
            <p>Klinefelter syndrome</p>
          </list-item>
          <list-item>
            <p>Congenital bicuspid aortic valve disease with associated aortopathy</p>
          </list-item>
          <list-item>
            <p>Aortic coarctation with associated ascending aortic enlargement</p>
          </list-item>
          <list-item>
            <p>Congenital bicuspid aortic valve disease with associated aortopathy</p>
          </list-item>
          <list-item>
            <p>Aortic coarctation with associated ascending aortic enlargement</p>
          </list-item>
          <list-item>
            <p>Familial thoracic aortic aneurysm or aortopathy</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-24744.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The lifespan of untreated patients with the classic&#x000a0;MFS was approximately 32 years in 1972 but has markedly increased to 72 years in 1993.<xref ref-type="bibr" rid="article-24744.r80">[80]</xref><xref ref-type="bibr" rid="article-24744.r81">[81]</xref>&#x000a0;Beta-blockers, noninvasive aortic imaging, and elective aortic root repair have all improved survival. Life expectancy is significantly lower in men than in women.&#x000a0;Patient longevity&#x000a0;is now almost similar to&#x000a0;persons without MFS. However, cardiovascular&#x000a0;impairment is still the most common cause of mortality, mainly because of sudden death&#x000a0;in an undiagnosed patient and in a newly diagnosed patient whose disease process has worsened beyond the scope of medical or surgical cure.</p>
      </sec>
      <sec id="article-24744.s12" sec-type="Complications">
        <title>Complications</title>
        <p>MFS has multisystem complications, which include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Aortic aneurysm and dissection</p>
          </list-item>
          <list-item>
            <p>Mitral valve prolapse</p>
          </list-item>
          <list-item>
            <p>Mitral regurgitation</p>
          </list-item>
          <list-item>
            <p>Aortic regurgitation</p>
          </list-item>
          <list-item>
            <p>Lens subluxation (ectopia lentis)</p>
          </list-item>
          <list-item>
            <p>Cataract, glaucoma, and retinal detachment</p>
          </list-item>
          <list-item>
            <p>Spontaneous pneumothorax</p>
          </list-item>
          <list-item>
            <p>Inguinal hernias</p>
          </list-item>
          <list-item>
            <p>Scoliosis</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-24744.s13" sec-type="Consultations">
        <title>Consultations</title>
        <p>Consultation with a cardiothoracic surgeon should be scheduled in patients whose aortic&#x000a0;diameter is more than 4 cm. Genetic counselor consultation is also&#x000a0;beneficial. Pregnant patients with MFS should consult a high-risk obstetrician. Ophthalmologic consultation is strongly considered in patients with cataracts, glaucoma, lens subluxation (ectopia lentis), and retinal detachment.</p>
      </sec>
      <sec id="article-24744.s14" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>MFS&#x000a0;may create a substantial mental and physical burden on the patient, with different areas of concern for each person. According to Rao et al,<xref ref-type="bibr" rid="article-24744.r82">[82]</xref> in the United States, the quality of life of patients with MFS is lower than that of&#x000a0;control subjects without the disease. Pain is&#x000a0;1 of the most common concerns for patients with MFS. A recent systematic review of the literature estimated that the prevalence of pain in these patients is 47%&#x000a0;to 92%.<xref ref-type="bibr" rid="article-24744.r83">[83]</xref> Adults with MFS report limited physical capacity, reduced endurance, and, ultimately, depression and anxiety. Through appropriate&#x000a0;diagnosis and treatment, along with timely rehabilitation, patients are better able to lead productive lives. Optimal treatment of chronic pain in patients with MFS should be a focus of future research.</p>
      </sec>
      <sec id="article-24744.s15" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Key facts to keep in mind about Marfan syndrome are as follows:</p>
        <list list-type="order">
          <list-item>
            <p>A diagnosis of MFS is based on characteristic manifestations, particularly aortic root&#x000a0;dilatation/dissection&#x000a0;and ectopia lentis, skeletal findings, mitral valve prolapse, dural ectasia, pneumothorax, and skin striae.</p>
          </list-item>
          <list-item>
            <p>Over 90% of patients with MFS have had <italic toggle="yes">FBN1</italic> mutations identified.</p>
          </list-item>
          <list-item>
            <p>Applying diagnostic criteria to individuals younger than 20 can be challenging because not all clinical features may manifest themselves.</p>
          </list-item>
          <list-item>
            <p>The aortic root Z-score is used to identify aortic dilatation associated with body size.</p>
          </list-item>
          <list-item>
            <p>First-degree relatives of patients with a gene mutation associated with aortic aneurysms&#x000a0;or&#x000a0;dissection (e.g., <italic toggle="yes">FBN1</italic>, <italic toggle="yes">TGFBR1</italic>, <italic toggle="yes">TGFBR2</italic>, <italic toggle="yes">COL3A1</italic>, <italic toggle="yes">ACTA2</italic>, <italic toggle="yes">MYH11</italic>) should undergo counseling, genetic testing, and potentially aortic imaging.<xref ref-type="bibr" rid="article-24744.r53">[53]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-24744.s16" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>MFS is a serious chronic disorder with no cure. A significant number of patients do develop life-threatening complications like aortic aneurysms and dissections, retinal detachment, aortic regurgitation, and pectus deformities. Management of MFS and its related complications involves an interprofessional team, including the patient's primary care provider, with appropriate referrals to a cardiologist, cardiothoracic surgeon, ophthalmologist, and orthopedics. Care coordination should occur between the different providers and the nurses taking care of these patients so that&#x000a0;they can quickly report any potential complications. Pharmacists should be aware of&#x000a0;medications that patients with MFS should avoid. Physical therapists should guide patients with MFS on appropriate&#x000a0;exercise activities, which should not include high-intensity&#x000a0;exercises. The key is close follow-up and monitoring for complications. The interprofessional team members should communicate with each other so that the patient is provided with the optimal standard of care treatment. The lifespan of untreated patients with the classic MFS was approximately 32 years in 1972 but has markedly increased to 72 years in 1993.<xref ref-type="bibr" rid="article-24744.r80">[80]</xref><xref ref-type="bibr" rid="article-24744.r81">[81]</xref>&#x000a0;Beta-blockers, noninvasive aortic imaging, and elective aortic root repair have all improved survival. Life expectancy is significantly lower in men than in women.</p>
      </sec>
      <sec id="article-24744.s17">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=24744&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=24744">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/genetic-disorders/marfan-syndrome/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=24744">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/24744/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=24744">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-24744.s18">
        <title>References</title>
        <ref id="article-24744.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Robinson</surname>
                <given-names>PN</given-names>
              </name>
              <name>
                <surname>Arteaga-Solis</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Baldock</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Collod-B&#x000e9;roud</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Booms</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>De Paepe</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dietz</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Guo</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Handford</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Judge</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Kielty</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Loeys</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Milewicz</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Ney</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ramirez</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Reinhardt</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Tiedemann</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Whiteman</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Godfrey</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>The molecular genetics of Marfan syndrome and related disorders.</article-title>
            <source>J Med Genet</source>
            <year>2006</year>
            <month>Oct</month>
            <volume>43</volume>
            <issue>10</issue>
            <fpage>769</fpage>
            <page-range>769-87</page-range>
            <pub-id pub-id-type="pmid">16571647</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Judge</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Dietz</surname>
                <given-names>HC</given-names>
              </name>
            </person-group>
            <article-title>Marfan's syndrome.</article-title>
            <source>Lancet</source>
            <year>2005</year>
            <month>Dec</month>
            <day>03</day>
            <volume>366</volume>
            <issue>9501</issue>
            <fpage>1965</fpage>
            <page-range>1965-76</page-range>
            <pub-id pub-id-type="pmid">16325700</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gould</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Sinha</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Aziz</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Rouf</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Dietz</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Judge</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Butcher</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Multi-scale biomechanical remodeling in aging and genetic mutant murine mitral valve leaflets: insights into Marfan syndrome.</article-title>
            <source>PLoS One</source>
            <year>2012</year>
            <volume>7</volume>
            <issue>9</issue>
            <fpage>e44639</fpage>
            <pub-id pub-id-type="pmid">22984535</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ammash</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Sundt</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Connolly</surname>
                <given-names>HM</given-names>
              </name>
            </person-group>
            <article-title>Marfan syndrome-diagnosis and management.</article-title>
            <source>Curr Probl Cardiol</source>
            <year>2008</year>
            <month>Jan</month>
            <volume>33</volume>
            <issue>1</issue>
            <fpage>7</fpage>
            <page-range>7-39</page-range>
            <pub-id pub-id-type="pmid">18155514</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r5">
          <label>5</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Dietz</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <chapter-title><italic>FBN1</italic>-Related Marfan Syndrome</chapter-title>
            <person-group person-group-type="editor">
              <name>
                <surname>Adam</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mirzaa</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Pagon</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Amemiya</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <source>GeneReviews<sup>&#x000ae;</sup> [Internet]</source>
            <publisher-name>University of Washington, Seattle</publisher-name>
            <publisher-loc>Seattle (WA)</publisher-loc>
            <year>2001</year>
            <month>4</month>
            <day>18</day>
            <pub-id pub-id-type="pmid">20301510</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dietz</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Cutting</surname>
                <given-names>GR</given-names>
              </name>
              <name>
                <surname>Pyeritz</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Maslen</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Sakai</surname>
                <given-names>LY</given-names>
              </name>
              <name>
                <surname>Corson</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Puffenberger</surname>
                <given-names>EG</given-names>
              </name>
              <name>
                <surname>Hamosh</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nanthakumar</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Curristin</surname>
                <given-names>SM</given-names>
              </name>
            </person-group>
            <article-title>Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene.</article-title>
            <source>Nature</source>
            <year>1991</year>
            <month>Jul</month>
            <day>25</day>
            <volume>352</volume>
            <issue>6333</issue>
            <fpage>337</fpage>
            <page-range>337-9</page-range>
            <pub-id pub-id-type="pmid">1852208</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Demetracopoulos</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Sponseller</surname>
                <given-names>PD</given-names>
              </name>
            </person-group>
            <article-title>Spinal deformities in Marfan syndrome.</article-title>
            <source>Orthop Clin North Am</source>
            <year>2007</year>
            <month>Oct</month>
            <volume>38</volume>
            <issue>4</issue>
            <fpage>563</fpage>
            <page-range>563-72, vii</page-range>
            <pub-id pub-id-type="pmid">17945136</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Murdoch</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Walker</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Halpern</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Kuzma</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>McKusick</surname>
                <given-names>VA</given-names>
              </name>
            </person-group>
            <article-title>Life expectancy and causes of death in the Marfan syndrome.</article-title>
            <source>N Engl J Med</source>
            <year>1972</year>
            <month>Apr</month>
            <day>13</day>
            <volume>286</volume>
            <issue>15</issue>
            <fpage>804</fpage>
            <page-range>804-8</page-range>
            <pub-id pub-id-type="pmid">5011789</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sponseller</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>Hobbs</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Riley</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Pyeritz</surname>
                <given-names>RE</given-names>
              </name>
            </person-group>
            <article-title>The thoracolumbar spine in Marfan syndrome.</article-title>
            <source>J Bone Joint Surg Am</source>
            <year>1995</year>
            <month>Jun</month>
            <volume>77</volume>
            <issue>6</issue>
            <fpage>867</fpage>
            <page-range>867-76</page-range>
            <pub-id pub-id-type="pmid">7782359</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Robins</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Moe</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Winter</surname>
                <given-names>RB</given-names>
              </name>
            </person-group>
            <article-title>Scoliosis in Marfan's syndrome. Its characteristics and results of treatment in thirty-five patients.</article-title>
            <source>J Bone Joint Surg Am</source>
            <year>1975</year>
            <month>Apr</month>
            <volume>57</volume>
            <issue>3</issue>
            <fpage>358</fpage>
            <page-range>358-68</page-range>
            <pub-id pub-id-type="pmid">1123390</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McKUSICK</surname>
                <given-names>VA</given-names>
              </name>
            </person-group>
            <article-title>The cardiovascular aspects of Marfan's syndrome: a heritable disorder of connective tissue.</article-title>
            <source>Circulation</source>
            <year>1955</year>
            <month>Mar</month>
            <volume>11</volume>
            <issue>3</issue>
            <fpage>321</fpage>
            <page-range>321-42</page-range>
            <pub-id pub-id-type="pmid">14352380</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Taub</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Stoler</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Perez-Sanz</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Chu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Isselbacher</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Picard</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Weyman</surname>
                <given-names>AE</given-names>
              </name>
            </person-group>
            <article-title>Mitral valve prolapse in Marfan syndrome: an old topic revisited.</article-title>
            <source>Echocardiography</source>
            <year>2009</year>
            <month>Apr</month>
            <volume>26</volume>
            <issue>4</issue>
            <fpage>357</fpage>
            <page-range>357-64</page-range>
            <pub-id pub-id-type="pmid">19054044</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maumenee</surname>
                <given-names>IH</given-names>
              </name>
            </person-group>
            <article-title>The eye in the Marfan syndrome.</article-title>
            <source>Birth Defects Orig Artic Ser</source>
            <year>1982</year>
            <volume>18</volume>
            <issue>6</issue>
            <fpage>515</fpage>
            <page-range>515-24</page-range>
            <pub-id pub-id-type="pmid">6983370</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sponseller</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>Erkula</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Skolasky</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Venuti</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Dietz</surname>
                <given-names>HC</given-names>
              </name>
            </person-group>
            <article-title>Improving clinical recognition of Marfan syndrome.</article-title>
            <source>J Bone Joint Surg Am</source>
            <year>2010</year>
            <month>Aug</month>
            <day>04</day>
            <volume>92</volume>
            <issue>9</issue>
            <fpage>1868</fpage>
            <page-range>1868-75</page-range>
            <pub-id pub-id-type="pmid">20686061</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Child</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Aragon-Martin</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Sage</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Genetic testing in Marfan syndrome.</article-title>
            <source>Br J Hosp Med (Lond)</source>
            <year>2016</year>
            <month>Jan</month>
            <volume>77</volume>
            <issue>1</issue>
            <fpage>38</fpage>
            <page-range>38-41</page-range>
            <pub-id pub-id-type="pmid">26903455</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shores</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Berger</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Murphy</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Pyeritz</surname>
                <given-names>RE</given-names>
              </name>
            </person-group>
            <article-title>Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan's syndrome.</article-title>
            <source>N Engl J Med</source>
            <year>1994</year>
            <month>May</month>
            <day>12</day>
            <volume>330</volume>
            <issue>19</issue>
            <fpage>1335</fpage>
            <page-range>1335-41</page-range>
            <pub-id pub-id-type="pmid">8152445</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hilhorst-Hofstee</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Rijlaarsdam</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Scholte</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Swart-van den Berg</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Versteegh</surname>
                <given-names>MI</given-names>
              </name>
              <name>
                <surname>van der Schoot-van Velzen</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Sch&#x000e4;bitz</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Bijlsma</surname>
                <given-names>EK</given-names>
              </name>
              <name>
                <surname>Baars</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Kerstjens-Frederikse</surname>
                <given-names>WS</given-names>
              </name>
              <name>
                <surname>Giltay</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Hamel</surname>
                <given-names>BC</given-names>
              </name>
              <name>
                <surname>Breuning</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Pals</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>The clinical spectrum of missense mutations of the first aspartic acid of cbEGF-like domains in fibrillin-1 including a recessive family.</article-title>
            <source>Hum Mutat</source>
            <year>2010</year>
            <month>Dec</month>
            <volume>31</volume>
            <issue>12</issue>
            <fpage>E1915</fpage>
            <page-range>E1915-27</page-range>
            <pub-id pub-id-type="pmid">20886638</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sakai</surname>
                <given-names>LY</given-names>
              </name>
              <name>
                <surname>Keene</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Glanville</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>B&#x000e4;chinger</surname>
                <given-names>HP</given-names>
              </name>
            </person-group>
            <article-title>Purification and partial characterization of fibrillin, a cysteine-rich structural component of connective tissue microfibrils.</article-title>
            <source>J Biol Chem</source>
            <year>1991</year>
            <month>Aug</month>
            <day>05</day>
            <volume>266</volume>
            <issue>22</issue>
            <fpage>14763</fpage>
            <page-range>14763-70</page-range>
            <pub-id pub-id-type="pmid">1860873</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dietz</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Ramirez</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Sakai</surname>
                <given-names>LY</given-names>
              </name>
            </person-group>
            <article-title>Marfan's syndrome and other microfibrillar diseases.</article-title>
            <source>Adv Hum Genet</source>
            <year>1994</year>
            <volume>22</volume>
            <fpage>153</fpage>
            <page-range>153-86</page-range>
            <pub-id pub-id-type="pmid">7762452</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reinhardt</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Keene</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Corson</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>P&#x000f6;schl</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>B&#x000e4;chinger</surname>
                <given-names>HP</given-names>
              </name>
              <name>
                <surname>Gambee</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Sakai</surname>
                <given-names>LY</given-names>
              </name>
            </person-group>
            <article-title>Fibrillin-1: organization in microfibrils and structural properties.</article-title>
            <source>J Mol Biol</source>
            <year>1996</year>
            <month>Apr</month>
            <day>26</day>
            <volume>258</volume>
            <issue>1</issue>
            <fpage>104</fpage>
            <page-range>104-16</page-range>
            <pub-id pub-id-type="pmid">8613981</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhang</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Ramirez</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Developmental expression of fibrillin genes suggests heterogeneity of extracellular microfibrils.</article-title>
            <source>J Cell Biol</source>
            <year>1995</year>
            <month>May</month>
            <volume>129</volume>
            <issue>4</issue>
            <fpage>1165</fpage>
            <page-range>1165-76</page-range>
            <pub-id pub-id-type="pmid">7744963</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>LeMaire</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Russell</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology of thoracic aortic dissection.</article-title>
            <source>Nat Rev Cardiol</source>
            <year>2011</year>
            <month>Feb</month>
            <volume>8</volume>
            <issue>2</issue>
            <fpage>103</fpage>
            <page-range>103-13</page-range>
            <pub-id pub-id-type="pmid">21173794</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hoffjan</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Genetic dissection of marfan syndrome and related connective tissue disorders: an update 2012.</article-title>
            <source>Mol Syndromol</source>
            <year>2012</year>
            <month>Aug</month>
            <volume>3</volume>
            <issue>2</issue>
            <fpage>47</fpage>
            <page-range>47-58</page-range>
            <pub-id pub-id-type="pmid">23326250</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Castellano</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Kovacic</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Sanz</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fuster</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Are we ignoring the dilated thoracic aorta?</article-title>
            <source>Ann N Y Acad Sci</source>
            <year>2012</year>
            <month>Apr</month>
            <volume>1254</volume>
            <fpage>164</fpage>
            <page-range>164-174</page-range>
            <pub-id pub-id-type="pmid">22548582</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bolar</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Van Laer</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Loeys</surname>
                <given-names>BL</given-names>
              </name>
            </person-group>
            <article-title>Marfan syndrome: from gene to therapy.</article-title>
            <source>Curr Opin Pediatr</source>
            <year>2012</year>
            <month>Aug</month>
            <volume>24</volume>
            <issue>4</issue>
            <fpage>498</fpage>
            <page-range>498-504</page-range>
            <pub-id pub-id-type="pmid">22705998</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Habashi</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Judge</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Holm</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Cohn</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Loeys</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>TK</given-names>
              </name>
              <name>
                <surname>Myers</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Klein</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Calvi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Podowski</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Neptune</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Halushka</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Bedja</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gabrielson</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Rifkin</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Carta</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ramirez</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Huso</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Dietz</surname>
                <given-names>HC</given-names>
              </name>
            </person-group>
            <article-title>Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome.</article-title>
            <source>Science</source>
            <year>2006</year>
            <month>Apr</month>
            <day>07</day>
            <volume>312</volume>
            <issue>5770</issue>
            <fpage>117</fpage>
            <page-range>117-21</page-range>
            <pub-id pub-id-type="pmid">16601194</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brooke</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Habashi</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Judge</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Loeys</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Dietz</surname>
                <given-names>HC</given-names>
              </name>
            </person-group>
            <article-title>Angiotensin II blockade and aortic-root dilation in Marfan's syndrome.</article-title>
            <source>N Engl J Med</source>
            <year>2008</year>
            <month>Jun</month>
            <day>26</day>
            <volume>358</volume>
            <issue>26</issue>
            <fpage>2787</fpage>
            <page-range>2787-95</page-range>
            <pub-id pub-id-type="pmid">18579813</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schlatmann</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Becker</surname>
                <given-names>AE</given-names>
              </name>
            </person-group>
            <article-title>Histologic changes in the normal aging aorta: implications for dissecting aortic aneurysm.</article-title>
            <source>Am J Cardiol</source>
            <year>1977</year>
            <month>Jan</month>
            <volume>39</volume>
            <issue>1</issue>
            <fpage>13</fpage>
            <page-range>13-20</page-range>
            <pub-id pub-id-type="pmid">831420</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schlatmann</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Becker</surname>
                <given-names>AE</given-names>
              </name>
            </person-group>
            <article-title>Pathogenesis of dissecting aneurysm of aorta. Comparative histopathologic study of significance of medial changes.</article-title>
            <source>Am J Cardiol</source>
            <year>1977</year>
            <month>Jan</month>
            <volume>39</volume>
            <issue>1</issue>
            <fpage>21</fpage>
            <page-range>21-6</page-range>
            <pub-id pub-id-type="pmid">831424</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Collins</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Dev</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Strauss</surname>
                <given-names>BH</given-names>
              </name>
              <name>
                <surname>Fedak</surname>
                <given-names>PW</given-names>
              </name>
              <name>
                <surname>Butany</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Variation in the histopathological features of patients with ascending aortic aneurysms: a study of 111 surgically excised cases.</article-title>
            <source>J Clin Pathol</source>
            <year>2008</year>
            <month>Apr</month>
            <volume>61</volume>
            <issue>4</issue>
            <fpage>519</fpage>
            <page-range>519-23</page-range>
            <pub-id pub-id-type="pmid">17938162</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hiratzka</surname>
                <given-names>LF</given-names>
              </name>
              <name>
                <surname>Bakris</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Beckman</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Bersin</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Carr</surname>
                <given-names>VF</given-names>
              </name>
              <name>
                <surname>Casey</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Eagle</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Hermann</surname>
                <given-names>LK</given-names>
              </name>
              <name>
                <surname>Isselbacher</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Kazerooni</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Kouchoukos</surname>
                <given-names>NT</given-names>
              </name>
              <name>
                <surname>Lytle</surname>
                <given-names>BW</given-names>
              </name>
              <name>
                <surname>Milewicz</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Reich</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Sen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Shinn</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Svensson</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>DM</given-names>
              </name>
              <collab>American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines</collab>
              <collab>American Association for Thoracic Surgery</collab>
              <collab>American College of Radiology</collab>
              <collab>American Stroke Association</collab>
              <collab>Society of Cardiovascular Anesthesiologists</collab>
              <collab>Society for Cardiovascular Angiography and Interventions</collab>
              <collab>Society of Interventional Radiology</collab>
              <collab>Society of Thoracic Surgeons</collab>
              <collab>Society for Vascular Medicine</collab>
            </person-group>
            <article-title>2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with Thoracic Aortic Disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine.</article-title>
            <source>Circulation</source>
            <year>2010</year>
            <month>Apr</month>
            <day>06</day>
            <volume>121</volume>
            <issue>13</issue>
            <fpage>e266</fpage>
            <page-range>e266-369</page-range>
            <pub-id pub-id-type="pmid">20233780</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Januzzi</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Isselbacher</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Fattori</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>JV</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Fang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Eagle</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Mehta</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Nienaber</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Pape</surname>
                <given-names>LA</given-names>
              </name>
              <collab>International Registry of Aortic Dissection (IRAD)</collab>
            </person-group>
            <article-title>Characterizing the young patient with aortic dissection: results from the International Registry of Aortic Dissection (IRAD).</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2004</year>
            <month>Feb</month>
            <day>18</day>
            <volume>43</volume>
            <issue>4</issue>
            <fpage>665</fpage>
            <page-range>665-9</page-range>
            <pub-id pub-id-type="pmid">14975480</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mehta</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>O'Gara</surname>
                <given-names>PT</given-names>
              </name>
              <name>
                <surname>Bossone</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Nienaber</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Myrmel</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>JV</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Armstrong</surname>
                <given-names>WF</given-names>
              </name>
              <name>
                <surname>Isselbacher</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Pape</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Eagle</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Gilon</surname>
                <given-names>D</given-names>
              </name>
              <collab>International Registry of Acute Aortic Dissection (IRAD) Investigators</collab>
            </person-group>
            <article-title>Acute type A aortic dissection in the elderly: clinical characteristics, management, and outcomes in the current era.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2002</year>
            <month>Aug</month>
            <day>21</day>
            <volume>40</volume>
            <issue>4</issue>
            <fpage>685</fpage>
            <page-range>685-92</page-range>
            <pub-id pub-id-type="pmid">12204498</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Svensson</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>Adams</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Bonow</surname>
                <given-names>RO</given-names>
              </name>
              <name>
                <surname>Kouchoukos</surname>
                <given-names>NT</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>O'Gara</surname>
                <given-names>PT</given-names>
              </name>
              <name>
                <surname>Shahian</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Schaff</surname>
                <given-names>HV</given-names>
              </name>
              <name>
                <surname>Akins</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Bavaria</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Blackstone</surname>
                <given-names>EH</given-names>
              </name>
              <name>
                <surname>David</surname>
                <given-names>TE</given-names>
              </name>
              <name>
                <surname>Desai</surname>
                <given-names>ND</given-names>
              </name>
              <name>
                <surname>Dewey</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>D'Agostino</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Gleason</surname>
                <given-names>TG</given-names>
              </name>
              <name>
                <surname>Harrington</surname>
                <given-names>KB</given-names>
              </name>
              <name>
                <surname>Kodali</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kapadia</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Leon</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Lima</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Lytle</surname>
                <given-names>BW</given-names>
              </name>
              <name>
                <surname>Mack</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Reece</surname>
                <given-names>TB</given-names>
              </name>
              <name>
                <surname>Reiss</surname>
                <given-names>GR</given-names>
              </name>
              <name>
                <surname>Roselli</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Thourani</surname>
                <given-names>VH</given-names>
              </name>
              <name>
                <surname>Tuzcu</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Webb</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>Aortic valve and ascending aorta guidelines for management and quality measures: executive summary.</article-title>
            <source>Ann Thorac Surg</source>
            <year>2013</year>
            <month>Apr</month>
            <volume>95</volume>
            <issue>4</issue>
            <fpage>1491</fpage>
            <page-range>1491-505</page-range>
            <pub-id pub-id-type="pmid">23291103</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rybczynski</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mir</surname>
                <given-names>TS</given-names>
              </name>
              <name>
                <surname>Sheikhzadeh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bernhardt</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Schad</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Treede</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Veldhoen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Groene</surname>
                <given-names>EF</given-names>
              </name>
              <name>
                <surname>K&#x000fc;hne</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Koschyk</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Robinson</surname>
                <given-names>PN</given-names>
              </name>
              <name>
                <surname>Berger</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Reichenspurner</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Meinertz</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>von Kodolitsch</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Frequency and age-related course of mitral valve dysfunction in the Marfan syndrome.</article-title>
            <source>Am J Cardiol</source>
            <year>2010</year>
            <month>Oct</month>
            <day>01</day>
            <volume>106</volume>
            <issue>7</issue>
            <fpage>1048</fpage>
            <page-range>1048-53</page-range>
            <pub-id pub-id-type="pmid">20854973</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Faivre</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Collod-Beroud</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Loeys</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Child</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Binquet</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gautier</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Callewaert</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Arbustini</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Mayer</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Arslan-Kirchner</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kiotsekoglou</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Comeglio</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Marziliano</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Dietz</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Halliday</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Beroud</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bonithon-Kopp</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Claustres</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Muti</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Plauchu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Robinson</surname>
                <given-names>PN</given-names>
              </name>
              <name>
                <surname>Ad&#x000e8;s</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Biggin</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Benetts</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Brett</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Holman</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>De Backer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Coucke</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Francke</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>De Paepe</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jondeau</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Boileau</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study.</article-title>
            <source>Am J Hum Genet</source>
            <year>2007</year>
            <month>Sep</month>
            <volume>81</volume>
            <issue>3</issue>
            <fpage>454</fpage>
            <page-range>454-66</page-range>
            <pub-id pub-id-type="pmid">17701892</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roman</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Devereux</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Kramer-Fox</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Spitzer</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>Comparison of cardiovascular and skeletal features of primary mitral valve prolapse and Marfan syndrome.</article-title>
            <source>Am J Cardiol</source>
            <year>1989</year>
            <month>Feb</month>
            <day>01</day>
            <volume>63</volume>
            <issue>5</issue>
            <fpage>317</fpage>
            <page-range>317-21</page-range>
            <pub-id pub-id-type="pmid">2913733</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moon</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Shin</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Chung</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>KY</given-names>
              </name>
            </person-group>
            <article-title>Newly developed aortic dissection after aorta cannulation during mitral valve surgery in a patient with marfan syndrome.</article-title>
            <source>Korean Circ J</source>
            <year>2012</year>
            <month>Jun</month>
            <volume>42</volume>
            <issue>6</issue>
            <fpage>437</fpage>
            <page-range>437-40</page-range>
            <pub-id pub-id-type="pmid">22787478</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>David</surname>
                <given-names>TE</given-names>
              </name>
              <name>
                <surname>Armstrong</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>McCrindle</surname>
                <given-names>BW</given-names>
              </name>
              <name>
                <surname>Manlhiot</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Late outcomes of mitral valve repair for mitral regurgitation due to degenerative disease.</article-title>
            <source>Circulation</source>
            <year>2013</year>
            <month>Apr</month>
            <day>09</day>
            <volume>127</volume>
            <issue>14</issue>
            <fpage>1485</fpage>
            <page-range>1485-92</page-range>
            <pub-id pub-id-type="pmid">23459614</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alpendurada</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kiotsekoglou</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Banya</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Child</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Prasad</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Pennell</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Mohiaddin</surname>
                <given-names>RH</given-names>
              </name>
            </person-group>
            <article-title>Evidence for Marfan cardiomyopathy.</article-title>
            <source>Eur J Heart Fail</source>
            <year>2010</year>
            <month>Oct</month>
            <volume>12</volume>
            <issue>10</issue>
            <fpage>1085</fpage>
            <page-range>1085-91</page-range>
            <pub-id pub-id-type="pmid">20861133</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Erkula</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>KB</given-names>
              </name>
              <name>
                <surname>Sponseller</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>Dietz</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Pyeritz</surname>
                <given-names>RE</given-names>
              </name>
            </person-group>
            <article-title>Growth and maturation in Marfan syndrome.</article-title>
            <source>Am J Med Genet</source>
            <year>2002</year>
            <month>Apr</month>
            <day>22</day>
            <volume>109</volume>
            <issue>2</issue>
            <fpage>100</fpage>
            <page-range>100-15</page-range>
            <pub-id pub-id-type="pmid">11977157</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lindsey</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Michelson</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>MacWilliams</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Sponseller</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>NH</given-names>
              </name>
            </person-group>
            <article-title>The foot in Marfan syndrome: clinical findings and weight-distribution patterns.</article-title>
            <source>J Pediatr Orthop</source>
            <year>1998</year>
            <season>Nov-Dec</season>
            <volume>18</volume>
            <issue>6</issue>
            <fpage>755</fpage>
            <page-range>755-9</page-range>
            <pub-id pub-id-type="pmid">9821131</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shirley</surname>
                <given-names>ED</given-names>
              </name>
              <name>
                <surname>Sponseller</surname>
                <given-names>PD</given-names>
              </name>
            </person-group>
            <article-title>Marfan syndrome.</article-title>
            <source>J Am Acad Orthop Surg</source>
            <year>2009</year>
            <month>Sep</month>
            <volume>17</volume>
            <issue>9</issue>
            <fpage>572</fpage>
            <page-range>572-81</page-range>
            <pub-id pub-id-type="pmid">19726741</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gjolaj</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Sponseller</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Newton</surname>
                <given-names>PO</given-names>
              </name>
              <name>
                <surname>Flynn</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Neubauer</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Marks</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Bastrom</surname>
                <given-names>TP</given-names>
              </name>
            </person-group>
            <article-title>Spinal deformity correction in Marfan syndrome versus adolescent idiopathic scoliosis: learning from the differences.</article-title>
            <source>Spine (Phila Pa 1976)</source>
            <year>2012</year>
            <month>Aug</month>
            <day>15</day>
            <volume>37</volume>
            <issue>18</issue>
            <fpage>1558</fpage>
            <page-range>1558-65</page-range>
            <pub-id pub-id-type="pmid">22426454</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jones</surname>
                <given-names>KB</given-names>
              </name>
              <name>
                <surname>Erkula</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Sponseller</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>Dormans</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>Spine deformity correction in Marfan syndrome.</article-title>
            <source>Spine (Phila Pa 1976)</source>
            <year>2002</year>
            <month>Sep</month>
            <day>15</day>
            <volume>27</volume>
            <issue>18</issue>
            <fpage>2003</fpage>
            <page-range>2003-12</page-range>
            <pub-id pub-id-type="pmid">12634560</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liang</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Qiu</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Shen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Comparison of posterior correction results between Marfan syndrome scoliosis and adolescent idiopathic scoliosis-a retrospective case-series study.</article-title>
            <source>J Orthop Surg Res</source>
            <year>2015</year>
            <month>May</month>
            <day>21</day>
            <volume>10</volume>
            <fpage>73</fpage>
            <pub-id pub-id-type="pmid">25990568</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thakkar</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Foran</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Mears</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Sponseller</surname>
                <given-names>PD</given-names>
              </name>
            </person-group>
            <article-title>Protrusio acetabuli and total hip arthroplasty in patients with Marfan syndrome.</article-title>
            <source>J Arthroplasty</source>
            <year>2012</year>
            <month>May</month>
            <volume>27</volume>
            <issue>5</issue>
            <fpage>776</fpage>
            <page-range>776-82</page-range>
            <pub-id pub-id-type="pmid">21975190</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tsipouras</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Del Mastro</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sarfarazi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Vitale</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Child</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Godfrey</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Devereux</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Hewett</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Steinmann</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Genetic linkage of the Marfan syndrome, ectopia lentis, and congenital contractural arachnodactyly to the fibrillin genes on chromosomes 15 and 5. The International Marfan Syndrome Collaborative Study.</article-title>
            <source>N Engl J Med</source>
            <year>1992</year>
            <month>Apr</month>
            <day>02</day>
            <volume>326</volume>
            <issue>14</issue>
            <fpage>905</fpage>
            <page-range>905-9</page-range>
            <pub-id pub-id-type="pmid">1542340</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Heur</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Costin</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Crowe</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Grimm</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Moran</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Svensson</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>Traboulsi</surname>
                <given-names>EI</given-names>
              </name>
            </person-group>
            <article-title>The value of keratometry and central corneal thickness measurements in the clinical diagnosis of Marfan syndrome.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2008</year>
            <month>Jun</month>
            <volume>145</volume>
            <issue>6</issue>
            <fpage>997</fpage>
            <page-range>997-1001</page-range>
            <pub-id pub-id-type="pmid">18378212</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pyeritz</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Fishman</surname>
                <given-names>EK</given-names>
              </name>
              <name>
                <surname>Bernhardt</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Siegelman</surname>
                <given-names>SS</given-names>
              </name>
            </person-group>
            <article-title>Dural ectasia is a common feature of the Marfan syndrome.</article-title>
            <source>Am J Hum Genet</source>
            <year>1988</year>
            <month>Nov</month>
            <volume>43</volume>
            <issue>5</issue>
            <fpage>726</fpage>
            <page-range>726-32</page-range>
            <pub-id pub-id-type="pmid">3189335</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Foran</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Pyeritz</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Dietz</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Sponseller</surname>
                <given-names>PD</given-names>
              </name>
            </person-group>
            <article-title>Characterization of the symptoms associated with dural ectasia in the Marfan patient.</article-title>
            <source>Am J Med Genet A</source>
            <year>2005</year>
            <month>Apr</month>
            <day>01</day>
            <volume>134A</volume>
            <issue>1</issue>
            <fpage>58</fpage>
            <page-range>58-65</page-range>
            <pub-id pub-id-type="pmid">15690402</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jones</surname>
                <given-names>KB</given-names>
              </name>
              <name>
                <surname>Myers</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Judge</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Kirby</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Dietz</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Sponseller</surname>
                <given-names>PD</given-names>
              </name>
            </person-group>
            <article-title>Toward an understanding of dural ectasia: a light microscopy study in a murine model of Marfan syndrome.</article-title>
            <source>Spine (Phila Pa 1976)</source>
            <year>2005</year>
            <month>Feb</month>
            <day>01</day>
            <volume>30</volume>
            <issue>3</issue>
            <fpage>291</fpage>
            <page-range>291-3</page-range>
            <pub-id pub-id-type="pmid">15682009</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Loeys</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Dietz</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Braverman</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Callewaert</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>De Backer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Devereux</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Hilhorst-Hofstee</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Jondeau</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Faivre</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Milewicz</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Pyeritz</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Sponseller</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>Wordsworth</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>De Paepe</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>The revised Ghent nosology for the Marfan syndrome.</article-title>
            <source>J Med Genet</source>
            <year>2010</year>
            <month>Jul</month>
            <volume>47</volume>
            <issue>7</issue>
            <fpage>476</fpage>
            <page-range>476-85</page-range>
            <pub-id pub-id-type="pmid">20591885</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cameron</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Alejo</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>ND</given-names>
              </name>
              <name>
                <surname>Nwakanma</surname>
                <given-names>LU</given-names>
              </name>
              <name>
                <surname>Weiss</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Vricella</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Dietz</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Spevak</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Bethea</surname>
                <given-names>BT</given-names>
              </name>
              <name>
                <surname>Fitton</surname>
                <given-names>TP</given-names>
              </name>
              <name>
                <surname>Gott</surname>
                <given-names>VL</given-names>
              </name>
            </person-group>
            <article-title>Aortic root replacement in 372 Marfan patients: evolution of operative repair over 30 years.</article-title>
            <source>Ann Thorac Surg</source>
            <year>2009</year>
            <month>May</month>
            <volume>87</volume>
            <issue>5</issue>
            <fpage>1344</fpage>
            <page-range>1344-9; discussion 1349-50</page-range>
            <pub-id pub-id-type="pmid">19379862</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Geisbuesch</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Schray</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bischoff</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Di Luozzo</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Griepp</surname>
                <given-names>RB</given-names>
              </name>
            </person-group>
            <article-title>Frequency of reoperations in patients with Marfan syndrome.</article-title>
            <source>Ann Thorac Surg</source>
            <year>2012</year>
            <month>May</month>
            <volume>93</volume>
            <issue>5</issue>
            <fpage>1496</fpage>
            <page-range>1496-501</page-range>
            <pub-id pub-id-type="pmid">22443865</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>David</surname>
                <given-names>TE</given-names>
              </name>
              <name>
                <surname>Armstrong</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Manlhiot</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>McCrindle</surname>
                <given-names>BW</given-names>
              </name>
              <name>
                <surname>Feindel</surname>
                <given-names>CM</given-names>
              </name>
            </person-group>
            <article-title>Long-term results of aortic root repair using the reimplantation technique.</article-title>
            <source>J Thorac Cardiovasc Surg</source>
            <year>2013</year>
            <month>Mar</month>
            <volume>145</volume>
            <issue>3 Suppl</issue>
            <fpage>S22</fpage>
            <page-range>S22-5</page-range>
            <pub-id pub-id-type="pmid">23260437</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Patel</surname>
                <given-names>ND</given-names>
              </name>
              <name>
                <surname>Weiss</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Alejo</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Nwakanma</surname>
                <given-names>LU</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Dietz</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Spevak</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Gott</surname>
                <given-names>VL</given-names>
              </name>
              <name>
                <surname>Vricella</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Cameron</surname>
                <given-names>DE</given-names>
              </name>
            </person-group>
            <article-title>Aortic root operations for Marfan syndrome: a comparison of the Bentall and valve-sparing procedures.</article-title>
            <source>Ann Thorac Surg</source>
            <year>2008</year>
            <month>Jun</month>
            <volume>85</volume>
            <issue>6</issue>
            <fpage>2003</fpage>
            <page-range>2003-10; discussion 2010-1</page-range>
            <pub-id pub-id-type="pmid">18498810</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alamri</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Alotaiby</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Almoghairi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>El Oakley</surname>
                <given-names>RM</given-names>
              </name>
            </person-group>
            <article-title>Lessons from the SYNTAX trial.</article-title>
            <source>J Saudi Heart Assoc</source>
            <year>2010</year>
            <month>Apr</month>
            <volume>22</volume>
            <issue>2</issue>
            <fpage>35</fpage>
            <page-range>35-41</page-range>
            <pub-id pub-id-type="pmid">23960592</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roman</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Rosen</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Kramer-Fox</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Devereux</surname>
                <given-names>RB</given-names>
              </name>
            </person-group>
            <article-title>Prognostic significance of the pattern of aortic root dilation in the Marfan syndrome.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>1993</year>
            <month>Nov</month>
            <day>01</day>
            <volume>22</volume>
            <issue>5</issue>
            <fpage>1470</fpage>
            <page-range>1470-6</page-range>
            <pub-id pub-id-type="pmid">8227807</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yetman</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Roosevelt</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Veit</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Everitt</surname>
                <given-names>MD</given-names>
              </name>
            </person-group>
            <article-title>Distal aortic and peripheral arterial aneurysms in patients with Marfan syndrome.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2011</year>
            <month>Dec</month>
            <day>06</day>
            <volume>58</volume>
            <issue>24</issue>
            <fpage>2544</fpage>
            <page-range>2544-5</page-range>
            <pub-id pub-id-type="pmid">22133857</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gaertner</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Alembik</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Cordeanu</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Dollfus</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Lejay</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chakfe</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Stephan</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Should we systematically screen for peripheral arterial aneurysms in all patients with Marfan syndrome?</article-title>
            <source>Int J Cardiol</source>
            <year>2014</year>
            <volume>172</volume>
            <issue>1</issue>
            <fpage>e94</fpage>
            <page-range>e94-5</page-range>
            <pub-id pub-id-type="pmid">24433614</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Groenink</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>de Roos</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mulder</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Spaan</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>van der Wall</surname>
                <given-names>EE</given-names>
              </name>
            </person-group>
            <article-title>Changes in aortic distensibility and pulse wave velocity assessed with magnetic resonance imaging following beta-blocker therapy in the Marfan syndrome.</article-title>
            <source>Am J Cardiol</source>
            <year>1998</year>
            <month>Jul</month>
            <day>15</day>
            <volume>82</volume>
            <issue>2</issue>
            <fpage>203</fpage>
            <page-range>203-8</page-range>
            <pub-id pub-id-type="pmid">9678292</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rossi-Foulkes</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Roman</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Rosen</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Kramer-Fox</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ehlers</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>O'Loughlin</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Devereux</surname>
                <given-names>RB</given-names>
              </name>
            </person-group>
            <article-title>Phenotypic features and impact of beta blocker or calcium antagonist therapy on aortic lumen size in the Marfan syndrome.</article-title>
            <source>Am J Cardiol</source>
            <year>1999</year>
            <month>May</month>
            <day>01</day>
            <volume>83</volume>
            <issue>9</issue>
            <fpage>1364</fpage>
            <page-range>1364-8</page-range>
            <pub-id pub-id-type="pmid">10235096</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Selamet Tierney</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Feingold</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Printz</surname>
                <given-names>BF</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Graham</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kleinman</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Mahnke</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Timchak</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Neches</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Gersony</surname>
                <given-names>WM</given-names>
              </name>
            </person-group>
            <article-title>Beta-blocker therapy does not alter the rate of aortic root dilation in pediatric patients with Marfan syndrome.</article-title>
            <source>J Pediatr</source>
            <year>2007</year>
            <month>Jan</month>
            <volume>150</volume>
            <issue>1</issue>
            <fpage>77</fpage>
            <page-range>77-82</page-range>
            <pub-id pub-id-type="pmid">17188619</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yetman</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Bornemeier</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>McCrindle</surname>
                <given-names>BW</given-names>
              </name>
            </person-group>
            <article-title>Usefulness of enalapril versus propranolol or atenolol for prevention of aortic dilation in patients with the Marfan syndrome.</article-title>
            <source>Am J Cardiol</source>
            <year>2005</year>
            <month>May</month>
            <day>01</day>
            <volume>95</volume>
            <issue>9</issue>
            <fpage>1125</fpage>
            <page-range>1125-7</page-range>
            <pub-id pub-id-type="pmid">15842990</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r66">
          <label>66</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chiu</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Chiu</surname>
                <given-names>SN</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>FC</given-names>
              </name>
            </person-group>
            <article-title>Losartan added to &#x003b2;-blockade therapy for aortic root dilation in Marfan syndrome: a randomized, open-label pilot study.</article-title>
            <source>Mayo Clin Proc</source>
            <year>2013</year>
            <month>Mar</month>
            <volume>88</volume>
            <issue>3</issue>
            <fpage>271</fpage>
            <page-range>271-6</page-range>
            <pub-id pub-id-type="pmid">23321647</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r67">
          <label>67</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Groenink</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>den Hartog</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Franken</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Radonic</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>de Waard</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Timmermans</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Scholte</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>van den Berg</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Spijkerboer</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Marquering</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Zwinderman</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Mulder</surname>
                <given-names>BJ</given-names>
              </name>
            </person-group>
            <article-title>Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial.</article-title>
            <source>Eur Heart J</source>
            <year>2013</year>
            <month>Dec</month>
            <volume>34</volume>
            <issue>45</issue>
            <fpage>3491</fpage>
            <page-range>3491-500</page-range>
            <pub-id pub-id-type="pmid">23999449</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r68">
          <label>68</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lacro</surname>
                <given-names>RV</given-names>
              </name>
              <name>
                <surname>Dietz</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Sleeper</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Yetman</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Bradley</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Colan</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Pearson</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Selamet Tierney</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Levine</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Atz</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Benson</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Braverman</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>De Backer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gelb</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>Grossfeld</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>Klein</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Lai</surname>
                <given-names>WW</given-names>
              </name>
              <name>
                <surname>Liou</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Loeys</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Markham</surname>
                <given-names>LW</given-names>
              </name>
              <name>
                <surname>Olson</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Paridon</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Pemberton</surname>
                <given-names>VL</given-names>
              </name>
              <name>
                <surname>Pierpont</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Pyeritz</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Radojewski</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Roman</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Sharkey</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Stylianou</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Wechsler</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Young</surname>
                <given-names>LT</given-names>
              </name>
              <name>
                <surname>Mahony</surname>
                <given-names>L</given-names>
              </name>
              <collab>Pediatric Heart Network Investigators</collab>
            </person-group>
            <article-title>Atenolol versus losartan in children and young adults with Marfan's syndrome.</article-title>
            <source>N Engl J Med</source>
            <year>2014</year>
            <month>Nov</month>
            <day>27</day>
            <volume>371</volume>
            <issue>22</issue>
            <fpage>2061</fpage>
            <page-range>2061-71</page-range>
            <pub-id pub-id-type="pmid">25405392</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r69">
          <label>69</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Williams</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kenny</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Fagenello</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Nelson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dunstan</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Cockcroft</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Stuart</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Fraser</surname>
                <given-names>AG</given-names>
              </name>
            </person-group>
            <article-title>Effects of atenolol, perindopril and verapamil on haemodynamic and vascular function in Marfan syndrome - a randomised, double-blind, crossover trial.</article-title>
            <source>Eur J Clin Invest</source>
            <year>2012</year>
            <month>Aug</month>
            <volume>42</volume>
            <issue>8</issue>
            <fpage>891</fpage>
            <page-range>891-9</page-range>
            <pub-id pub-id-type="pmid">22471392</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r70">
          <label>70</label>
          <element-citation publication-type="journal">
            <article-title>Notice of Retraction: Ahimastos AA, et al. Effect of Perindopril on Large Artery Stiffness and Aortic Root Diameter in Patients With Marfan Syndrome: A Randomized Controlled Trial. JAMA. 2007;298(13):1539-1547.</article-title>
            <source>JAMA</source>
            <year>2015</year>
            <month>Dec</month>
            <day>22-29</day>
            <volume>314</volume>
            <issue>24</issue>
            <fpage>2692</fpage>
            <page-range>2692-3</page-range>
            <pub-id pub-id-type="pmid">26594834</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r71">
          <label>71</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McLoughlin</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>McGuinness</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Byrne</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Terzo</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Huuskonen</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>McAllister</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Black</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kearney</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kay</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hill</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Dietz</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Redmond</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Pravastatin reduces Marfan aortic dilation.</article-title>
            <source>Circulation</source>
            <year>2011</year>
            <month>Sep</month>
            <day>13</day>
            <volume>124</volume>
            <issue>11 Suppl</issue>
            <fpage>S168</fpage>
            <page-range>S168-73</page-range>
            <pub-id pub-id-type="pmid">21911808</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r72">
          <label>72</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Doyle</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Doyle</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>NK</given-names>
              </name>
              <name>
                <surname>Habashi</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Bedja</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Whitworth</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Lindsay</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Schoenhoff</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Myers</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Huso</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Bachir</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Squires</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Rusholme</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ehsan</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Huso</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Caulfield</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Van Eyk</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Judge</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Dietz</surname>
                <given-names>HC</given-names>
              </name>
              <collab>GenTAC Registry Consortium</collab>
              <collab>MIBAVA Leducq Consortium</collab>
            </person-group>
            <article-title>A deleterious gene-by-environment interaction imposed by calcium channel blockers in Marfan syndrome.</article-title>
            <source>Elife</source>
            <year>2015</year>
            <month>Oct</month>
            <day>27</day>
            <volume>4</volume>
            <pub-id pub-id-type="pmid">26506064</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r73">
          <label>73</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maron</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Chaitman</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Ackerman</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Bay&#x000e9;s de Luna</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Corrado</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Crosson</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Deal</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Driscoll</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Estes</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Ara&#x000fa;jo</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Liang</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Mitten</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Myerburg</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Pelliccia</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>Towbin</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Van Camp</surname>
                <given-names>SP</given-names>
              </name>
              <collab>Working Groups of the American Heart Association Committee on Exercise, Cardiac Rehabilitation, and Prevention</collab>
              <collab>Councils on Clinical Cardiology and Cardiovascular Disease in the Young</collab>
            </person-group>
            <article-title>Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases.</article-title>
            <source>Circulation</source>
            <year>2004</year>
            <month>Jun</month>
            <day>08</day>
            <volume>109</volume>
            <issue>22</issue>
            <fpage>2807</fpage>
            <page-range>2807-16</page-range>
            <pub-id pub-id-type="pmid">15184297</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r74">
          <label>74</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gott</surname>
                <given-names>VL</given-names>
              </name>
              <name>
                <surname>Greene</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Alejo</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Cameron</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Naftel</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Gillinov</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Laschinger</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Pyeritz</surname>
                <given-names>RE</given-names>
              </name>
            </person-group>
            <article-title>Replacement of the aortic root in patients with Marfan's syndrome.</article-title>
            <source>N Engl J Med</source>
            <year>1999</year>
            <month>Apr</month>
            <day>29</day>
            <volume>340</volume>
            <issue>17</issue>
            <fpage>1307</fpage>
            <page-range>1307-13</page-range>
            <pub-id pub-id-type="pmid">10219065</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r75">
          <label>75</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gott</surname>
                <given-names>VL</given-names>
              </name>
            </person-group>
            <article-title>Antoine Marfan and his syndrome: one hundred years later.</article-title>
            <source>Md Med J</source>
            <year>1998</year>
            <month>Nov</month>
            <volume>47</volume>
            <issue>5</issue>
            <fpage>247</fpage>
            <page-range>247-52</page-range>
            <pub-id pub-id-type="pmid">9798380</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r76">
          <label>76</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Svensson</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>Khitin</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Aortic cross-sectional area/height ratio timing of aortic surgery in asymptomatic patients with Marfan syndrome.</article-title>
            <source>J Thorac Cardiovasc Surg</source>
            <year>2002</year>
            <month>Feb</month>
            <volume>123</volume>
            <issue>2</issue>
            <fpage>360</fpage>
            <page-range>360-1</page-range>
            <pub-id pub-id-type="pmid">11828302</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r77">
          <label>77</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zanotti</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Vricella</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Cameron</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Thoracic aortic aneurysm syndrome in children.</article-title>
            <source>Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu</source>
            <year>2008</year>
            <fpage>11</fpage>
            <page-range>11-21</page-range>
            <pub-id pub-id-type="pmid">18396220</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r78">
          <label>78</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Donnelly</surname>
                <given-names>RT</given-names>
              </name>
              <name>
                <surname>Pinto</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Kocolas</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Yetman</surname>
                <given-names>AT</given-names>
              </name>
            </person-group>
            <article-title>The immediate and long-term impact of pregnancy on aortic growth rate and mortality in women with Marfan syndrome.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2012</year>
            <month>Jul</month>
            <day>17</day>
            <volume>60</volume>
            <issue>3</issue>
            <fpage>224</fpage>
            <page-range>224-9</page-range>
            <pub-id pub-id-type="pmid">22789886</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r79">
          <label>79</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tang</surname>
                <given-names>GH</given-names>
              </name>
              <name>
                <surname>Malekan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lansman</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Spielvogel</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Aortic valve-sparing reimplantation and mitral repair in a pregnant, second trimester Marfan patient: surgical decision.</article-title>
            <source>Ann Thorac Surg</source>
            <year>2013</year>
            <month>Feb</month>
            <volume>95</volume>
            <issue>2</issue>
            <fpage>701</fpage>
            <page-range>701-3</page-range>
            <pub-id pub-id-type="pmid">23336884</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r80">
          <label>80</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Finkbohner</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Johnston</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Crawford</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Coselli</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Milewicz</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>Marfan syndrome. Long-term survival and complications after aortic aneurysm repair.</article-title>
            <source>Circulation</source>
            <year>1995</year>
            <month>Feb</month>
            <day>01</day>
            <volume>91</volume>
            <issue>3</issue>
            <fpage>728</fpage>
            <page-range>728-33</page-range>
            <pub-id pub-id-type="pmid">7828300</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r81">
          <label>81</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Silverman</surname>
                <given-names>DI</given-names>
              </name>
              <name>
                <surname>Burton</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Gray</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bosner</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Kouchoukos</surname>
                <given-names>NT</given-names>
              </name>
              <name>
                <surname>Roman</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Boxer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Devereux</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Tsipouras</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Life expectancy in the Marfan syndrome.</article-title>
            <source>Am J Cardiol</source>
            <year>1995</year>
            <month>Jan</month>
            <day>15</day>
            <volume>75</volume>
            <issue>2</issue>
            <fpage>157</fpage>
            <page-range>157-60</page-range>
            <pub-id pub-id-type="pmid">7810492</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r82">
          <label>82</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rao</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Venuti</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Dietz</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Sponseller</surname>
                <given-names>PD</given-names>
              </name>
            </person-group>
            <article-title>Quantifying Health Status and Function in Marfan Syndrome.</article-title>
            <source>J Surg Orthop Adv</source>
            <year>2016</year>
            <season>Spring</season>
            <volume>25</volume>
            <issue>1</issue>
            <fpage>34</fpage>
            <page-range>34-40</page-range>
            <pub-id pub-id-type="pmid">27082886</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24744.r83">
          <label>83</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Velvin</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bathen</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Rand-Hendriksen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Geirdal</surname>
                <given-names>A&#x000d8;</given-names>
              </name>
            </person-group>
            <article-title>Systematic review of chronic pain in persons with Marfan syndrome.</article-title>
            <source>Clin Genet</source>
            <year>2016</year>
            <month>Jun</month>
            <volume>89</volume>
            <issue>6</issue>
            <fpage>647</fpage>
            <page-range>647-58</page-range>
            <pub-id pub-id-type="pmid">26607862</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
